242 related articles for article (PubMed ID: 23592914)
21. Sildenafil attenuates vaso-obliteration and neovascularization in a mouse model of retinopathy of prematurity.
Fawzi AA; Chou JC; Kim GA; Rollins SD; Taylor JM; Farrow KN
Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1493-501. PubMed ID: 24519428
[TBL] [Abstract][Full Text] [Related]
22. Relationship between Pericytes and Endothelial Cells in Retinal Neovascularization: A Histological and Immunofluorescent Study of Retinal Angiogenesis.
Choi SH; Chung M; Park SW; Jeon NL; Kim JH; Yu YS
Korean J Ophthalmol; 2018 Feb; 32(1):70-76. PubMed ID: 29376221
[TBL] [Abstract][Full Text] [Related]
23. Involvement of Nox2 NADPH oxidase in retinal neovascularization.
Chan EC; van Wijngaarden P; Liu GS; Jiang F; Peshavariya H; Dusting GJ
Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):7061-7. PubMed ID: 24106122
[TBL] [Abstract][Full Text] [Related]
24. HIF-2alpha-haploinsufficient mice have blunted retinal neovascularization due to impaired expression of a proangiogenic gene battery.
Dioum EM; Clarke SL; Ding K; Repa JJ; Garcia JA
Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2714-20. PubMed ID: 18281611
[TBL] [Abstract][Full Text] [Related]
25. Hypericin inhibits pathological retinal neovascularization in a mouse model of oxygen-induced retinopathy.
Higuchi A; Yamada H; Yamada E; Jo N; Matsumura M
Mol Vis; 2008 Feb; 14():249-54. PubMed ID: 18334941
[TBL] [Abstract][Full Text] [Related]
26. β‑elemene inhibits oxygen‑induced retinal neovascularization via promoting miR‑27a and reducing VEGF expression.
Zhang W; Chen L; Geng J; Liu L; Xu L
Mol Med Rep; 2019 Mar; 19(3):2307-2316. PubMed ID: 30664207
[TBL] [Abstract][Full Text] [Related]
27. Retro-orbital injection of FITC-dextran is an effective and economical method for observing mouse retinal vessels.
Li S; Li T; Luo Y; Yu H; Sun Y; Zhou H; Liang X; Huang J; Tang S
Mol Vis; 2011; 17():3566-73. PubMed ID: 22219652
[TBL] [Abstract][Full Text] [Related]
28. Spatial pattern and temporal evolution of retinal oxygenation response in oxygen-induced retinopathy.
Roberts R; Zhang W; Ito Y; Berkowitz BA
Invest Ophthalmol Vis Sci; 2003 Dec; 44(12):5315-20. PubMed ID: 14638732
[TBL] [Abstract][Full Text] [Related]
29. The effect of thalidomide on neovascularization in a mouse model of retinopathy of prematurity.
Rabinowitz R; Katz G; Rosner M; Pri-Chen S; Spierer A
Graefes Arch Clin Exp Ophthalmol; 2008 Jun; 246(6):843-8. PubMed ID: 18343940
[TBL] [Abstract][Full Text] [Related]
30. Neuropeptide Y expression in a mouse model of oxygen-induced retinopathy.
Yoon HZ; Yan Y; Geng Y; Higgins RD
Clin Exp Ophthalmol; 2002 Dec; 30(6):424-9. PubMed ID: 12427234
[TBL] [Abstract][Full Text] [Related]
31. Hyperoxia causes reduced density of retinal astrocytes in the central avascular zone in the mouse model of oxygen-induced retinopathy.
Bucher F; Stahl A; Agostini HT; Martin G
Mol Cell Neurosci; 2013 Sep; 56():225-33. PubMed ID: 23756201
[TBL] [Abstract][Full Text] [Related]
32. Role of hypoxia-inducible factor-1α and survivin in oxygen-induced retinopathy in mice.
Liu N; Sun Y; Zhao N; Chen L
Int J Clin Exp Pathol; 2014; 7(10):6814-9. PubMed ID: 25400763
[TBL] [Abstract][Full Text] [Related]
33. Expression and activation of STAT3 in ischemia-induced retinopathy.
Mechoulam H; Pierce EA
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4409-16. PubMed ID: 16303927
[TBL] [Abstract][Full Text] [Related]
34. RhoA activation and effect of Rho-kinase inhibitor in the development of retinal neovascularization in a mouse model of oxygen-induced retinopathy.
Fang X; Ueno M; Yamashita T; Ikuno Y
Curr Eye Res; 2011 Nov; 36(11):1028-36. PubMed ID: 21999228
[TBL] [Abstract][Full Text] [Related]
35. CCR7/p-ERK1/2/VEGF signaling promotes retinal neovascularization in a mouse model of oxygen-induced retinopathy.
Yuan LH; Chen XL; Di Y; Liu ML
Int J Ophthalmol; 2017; 10(6):862-869. PubMed ID: 28730075
[TBL] [Abstract][Full Text] [Related]
36. Correspondence of retinal thinning and vasculopathy in mice with oxygen-induced retinopathy.
Mezu-Ndubuisi OJ; Wanek J; Chau FY; Teng PY; Blair NP; Reddy NM; Raj JU; Reddy SP; Shahidi M
Exp Eye Res; 2014 May; 122():119-22. PubMed ID: 24703909
[TBL] [Abstract][Full Text] [Related]
37. CEACAM1 confers resistance toward oxygen-induced vessel damage in a mouse model of retinopathy of prematurity.
Ludewig P; Flachsbarth K; Wegscheid C; Tiegs G; Richard G; Wagener C; Bartsch U; Horst AK
Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):7950-60. PubMed ID: 25406283
[TBL] [Abstract][Full Text] [Related]
38. Norrin treatment improves ganglion cell survival in an oxygen-induced retinopathy model of retinal ischemia.
Dailey WA; Drenser KA; Wong SC; Cheng M; Vercellone J; Roumayah KK; Feeney EV; Deshpande M; Guzman AE; Trese M; Mitton KP
Exp Eye Res; 2017 Nov; 164():129-138. PubMed ID: 28823941
[TBL] [Abstract][Full Text] [Related]
39. Activation of retinal microglia rather than microglial cell density correlates with retinal neovascularization in the mouse model of oxygen-induced retinopathy.
Fischer F; Martin G; Agostini HT
J Neuroinflammation; 2011 Sep; 8():120. PubMed ID: 21943408
[TBL] [Abstract][Full Text] [Related]
40. A murine model for retinopathy of prematurity identifies endothelial cell proliferation as a potential mechanism for plus disease.
Guaiquil VH; Hewing NJ; Chiang MF; Rosenblatt MI; Chan RV; Blobel CP
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5294-302. PubMed ID: 23833070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
